DK0691404T3 - Vaccine for immunization against TBE virus infections as well as a method for their preparation - Google Patents

Vaccine for immunization against TBE virus infections as well as a method for their preparation

Info

Publication number
DK0691404T3
DK0691404T3 DK95890132T DK95890132T DK0691404T3 DK 0691404 T3 DK0691404 T3 DK 0691404T3 DK 95890132 T DK95890132 T DK 95890132T DK 95890132 T DK95890132 T DK 95890132T DK 0691404 T3 DK0691404 T3 DK 0691404T3
Authority
DK
Denmark
Prior art keywords
vaccine
preparation
well
virus infections
immunization against
Prior art date
Application number
DK95890132T
Other languages
Danish (da)
Inventor
Xaver Prof Dr Heinz Franz
Dr Allison Steven
Doz Dr Mandl Christian
Prof Dr Kunz Christian
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0135294A external-priority patent/AT402897B/en
Priority claimed from AT0087195A external-priority patent/AT405607B/en
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK0691404T3 publication Critical patent/DK0691404T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24161—Methods of inactivation or attenuation
    • C12N2770/24162—Methods of inactivation or attenuation by genetic engineering
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Vaccine against flavivirus infections comprises nucleic acid encoding flavivirus proteins E and prM/M in full-length native form. Also claimed is a nucleic acid vector comprising the entire protein prM/M and E coding sequence of a flavivirus, provided that it is not an SV40-based plasmid vector.
DK95890132T 1994-07-08 1995-07-06 Vaccine for immunization against TBE virus infections as well as a method for their preparation DK0691404T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0135294A AT402897B (en) 1994-07-08 1994-07-08 Improved vaccine for immunization against tbe virus infections, and a process for its production
AT0087195A AT405607B (en) 1995-05-23 1995-05-23 Improved vaccine for immunizing against TBE virus infections, and a process for the preparation thereof

Publications (1)

Publication Number Publication Date
DK0691404T3 true DK0691404T3 (en) 2001-03-19

Family

ID=25594155

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98107383T DK0869184T3 (en) 1994-07-08 1995-07-06 Vaccine for immunization against TBE virus infections as well as a method for their preparation
DK95890132T DK0691404T3 (en) 1994-07-08 1995-07-06 Vaccine for immunization against TBE virus infections as well as a method for their preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK98107383T DK0869184T3 (en) 1994-07-08 1995-07-06 Vaccine for immunization against TBE virus infections as well as a method for their preparation

Country Status (9)

Country Link
EP (2) EP0869184B1 (en)
AT (2) ATE206459T1 (en)
CZ (1) CZ282927B6 (en)
DE (2) DE59508988D1 (en)
DK (2) DK0869184T3 (en)
ES (2) ES2155510T3 (en)
FI (2) FI117974B (en)
HU (2) HU219503B (en)
RU (1) RU2150294C1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE316796T1 (en) * 1997-11-20 2006-02-15 Us Army Medical Res And Materi DNA VACCINES AGAINST TICK FLAVEVATION
US7425437B2 (en) 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
NZ535690A (en) 2002-02-26 2009-04-30 Maxygen Inc Novel flavivirus antigens
CA2591665C (en) 2004-12-20 2015-05-05 Crucell Holland B.V. Binding molecules capable of neutralizing west nile virus and uses thereof
ATE507242T1 (en) 2005-05-12 2011-05-15 Crucell Holland Bv HOST CELL-SPECIFIC BINDING MOLECULES CAPABILITY OF NEUTRALIZING VIRUSES AND APPLICATIONS THEREOF
MX2008014977A (en) 2006-06-06 2008-12-05 Crucell Holland Bv Human binding molecules having killing activity against staphylococci and uses thereof.
CA2960659C (en) 2007-11-09 2021-07-13 The Salk Institute For Biological Studies Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE122055T1 (en) * 1987-03-20 1995-05-15 Immuno Ag DNA AND RNA MOLECULES OF THE WESTERN SUBTYPE OF TBE VIRUS, POLYPEPTIDES ENCODED BY THESE MOLECULES, AND THEIR USE.
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
WO1992003161A1 (en) 1990-08-27 1992-03-05 The United States Of America, Represented By The Secretary, United States Department Of Commerce Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
CA2102918C (en) 1992-03-11 2007-05-08 Joel R. Haynes Genetic vaccine for immunodeficiency viruses

Also Published As

Publication number Publication date
ATE198909T1 (en) 2001-02-15
ES2165109T3 (en) 2002-03-01
RU2150294C1 (en) 2000-06-10
HU219503B (en) 2001-04-28
EP0869184A2 (en) 1998-10-07
EP0869184B1 (en) 2001-10-04
DE59509667D1 (en) 2001-11-08
EP0691404B1 (en) 2001-01-24
FI953371A0 (en) 1995-07-07
HU224199B1 (en) 2005-06-28
HU9903233D0 (en) 1999-11-29
FI118222B (en) 2007-08-31
CZ282927B6 (en) 1997-11-12
HUT72395A (en) 1996-04-29
EP0691404A2 (en) 1996-01-10
EP0869184A3 (en) 1999-05-12
DK0869184T3 (en) 2001-12-17
ES2155510T3 (en) 2001-05-16
CZ176995A3 (en) 1996-01-17
DE59508988D1 (en) 2001-03-01
ATE206459T1 (en) 2001-10-15
FI20070041A (en) 2007-01-17
HU9501832D0 (en) 1995-08-28
FI953371A (en) 1996-01-09
EP0691404A3 (en) 1997-11-12
FI117974B (en) 2007-05-15

Similar Documents

Publication Publication Date Title
DE69829668D1 (en) PREPARATION AND USE OF RECOMBINANT INFLUENZA A VIRUS M2 CONSTRUCTIONS AND IMPORTS
CY1106350T1 (en) TUBERCULOSIS VACCINE
DE58906121D1 (en) Recombinant vaccinia virus MVA.
EP1847549A3 (en) Papillomavirus polyprotein constructs
FI20070041A (en) Improved vaccine for immunization against Flavivirus infections
CY1105600T1 (en) NUCLEIC ACID CONSTRUCTS FOR GENETIC IMMUNIZATION
BR9605153B1 (en) combination vaccine and vaccination kit.
ATE215124T1 (en) VACCINE COMPOSITIONS CONTAINING RECOMBINANT TETC-FUSION PROTEIN
DK606285A (en) VACCINE v. RABIES AND PROCEDURE FOR PREPARING THEREOF
HUT71847A (en) Dna molecules encoding aminopeptidase enzymes, vectors and transgenic cells containing dna molecules, immunogenic polypeptides encoding by dna molecules, vaccines against helminth infections containing these peptides and process for the preparation ...
WO2002062296A3 (en) Methods and compositions useful for stimulating an immune response
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
DK0892054T3 (en) Clostridium perfringens vaccine
DK457687A (en) ANTIGENIC ACTIVE PROTEINS AND PEPTIDES AND VACCINES AGAINST VIRUS FOR FELIN PERITONITIS (FIPV) CONTAINING SUCH PROTEIN OR PEPTIDES
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
ZA896942B (en) Allelic variants of plasmodium falciparum merozoite surface antigen
DK381787A (en) PURIFIED ANTIGENES WITH VACCINE PROPERTIES AGAINST B. PERTUSSIS, AGENTS, NAME RECOMBINANT DNA, FOR PRODUCING THEREOF AND VACCINE PREPARATIONS CONTAINING THESE
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
AR010517A1 (en) COMPOUNDS AND METHODS FOR TUBERCULOSIS IMMUNOTHERAPY AND DIAGNOSIS
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.